Biosynex Nordic ApS: Financial statements 2019
CVR: 38417541
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 230,642 and a net result of DKK 177,948 compared with DKK -29,443 the year before. Equity in the 2019 report amounted to DKK 199,169. The solvency ratio was 39.5%.
- Gross Profit
- DKK 230,642
- Profit/Loss
- DKK 177,948
- Equity
- DKK 199,169
- Total Assets
- DKK 504,414
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 231K | 178K | 199K | 0 |
| 2018 | - | -35K | -29K | 21K | 0 |
| 2017 | 356K | 840 | 664 | 51K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Biosynex Nordic ApS has published its annual report for 2018. Gross profit came to DKK -35,113, and the net result was DKK -29,443.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.